CVS Health to expand Registered Apprenticeship program
CVS Health said Monday it will be expanding its Registered Apprenticeship program to include new markets and fields of study. Read More »
Study finds rise in prescription drug use by Americans
Use of prescription drugs among adults in the United States has drastically increased since the turn of the 21st century, a study published Tuesday in the Journal of the American Medical Association said. Read More »
Pharmaceutical firms must implement packaging serialization in EU countries by 2019
The pharmaceutical industry is being forced to undergo an extensive transformation as the serialization of prescription medicine packages to verify the origins of a given medicine will be mandatory in all European Union countries by 2019. Read More »
Bristol-Myers enhances heart treatment pipeline through Cardioxyl acquisition
Bristol-Myers Squibb has entered into a deal to acquire all issued and outstanding capital stock of Cardioxyl Pharmaceuticals, Inc. Read More »
Parkinson's disease psychosis drug Nuplazid granted FDA priority review
The FDA has granted priority review of Acadia Pharmaceuticals' new drug application (NDA) for Nuplazid (pimavanserin) that is intended to treat Parkinson's disease psychosis. Read More »
ASHP puts out call for co-sponsors on provider status legislation
The American Society of Health-System Pharmacists (ASHP) said legislation pending in the U.S. House of Representatives that would help the medically underserved needs four more co-sponsors to get to the next phase. Read More »
Lilly, AstraZeneca to expand immuno-oncology collaboration
AstraZeneca and Eli Lilly and Co. said recently they will expand their present immuno-oncology collaboration to develop innovative combination therapy options for patients with solid tumors. Read More »
Strensiq approved to treat rare genetic disorder HPP
The U.S. Food and Drug Administration approved Strensiq (asfotase alfa) to treat perinatal, infantile and juvenile-onset hypophosphatasia (HPP), a rare, genetic, progressive, metabolic disease. Read More »
FDA approves Veltassa treat hyperkalemia
The U.S. Food and Drug Administration (FDA) recently approved Veltassa (patiromer for oral suspension) to treat patients with elevated levels of potassium in the blood, a condition known as hyperkalemia. Read More »
Report: Federal Medicaid program could have seen savings if Affordable Care Act standards were used in New York
The U.S. Department of Health and Human Services Office of Inspector General said recently the federal Medicaid program could have realized savings if New York had applied medical loss ratio standards like those set in the Affordable Care Act (ACA). Read More »
Study shows cholesterol-lowering statins are underused
Patients with high cholesterol are prescribed statins, but a recent study said about half of these patients will stop using the medication within the first year. Read More »
Cigna enters alliance to improve health care, reduce costs in Central Florida
Cigna and Central Florida Affordable Care LLC announced on Thursday a collaboration to lower costs while improving health care and patient experience under Cigna’s accountable care organizations program called Cigna Collaborative Care. Read More »
Severe acne treatment is delayed by ineffective antibiotics
A study of records at New York University's Langone Medical Center determined that too many patients being treated for severe acne are being left on ineffective antibiotics for too long before being prescribed isotretinoin (also known by its former brand name Accutane). Read More »
FDA to delay enforcement of Track and Trace requirements
Track and Trace requirements scheduled to go into effect Sunday have been delayed until March 1, according to a Thursday announcement from the Food and Drug Administration (FDA). Read More »
Arena Pharmaceuticals initiates Phase 1b trial of APD371
Arena Pharmaceuticals Inc. has begun patient dosing in a Phase 1b multiple-ascending dose clinical trial of APD371, a selective agonist of the cannabinoid 2 (CB2) receptor. Read More »
FDA approves first-of-its-kind melanoma treatment
Imlygic (talimogene laherparepvec) has become the first FDA-approved oncolytic virus therapy indicated for the treatment of melanoma lesions in the skin and lymph nodes. Read More »
FDA approves Merrimack's Onivyde as pancreatic cancer treatment
PharmaEngine Inc. recently announced the U.S. Food and Drug Administration's (FDA) approval of Merimack's Onivyde (irinotecan liposome injection) in combination with fluorouracil (5-FU) and leucovorin (LV). Read More »
ASHP updates best practices resource
The American Society of Health-System Pharmacists (ASHP) recently published its annual compilation, ASHP Best Practices, featuring information such as quality policy positions, statements, guidelines, therapeutic position statements, and therapeutic and clinical practice guidelines for the pharmacy profession. Read More »
ClearPath Development launches second vaccine company
ClearPath Development Co. has partnered with Astellas Pharma Inc. to form a second vaccine company, Nosocomial Vaccine Corp. (NVC). Read More »
CVS opens 1,000th MinuteClinic facility
CVS Health's walk-in medical clinic, MinuteClinic, reached a milestone recently with the opening of its 1,000th location on Dupont Circle in Washington, D.C. Read More »
Alerts Sign-up